Top compounds associated with response to ST20-MTHFS


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.085 0.003
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.003
mRNA ATRA CTRPv2 pan-cancer AAC -0.1 0.003
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.11 0.003
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.003
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.004
Download CSV